A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
In conclusion, compared with warfarin, dabigatran treatment was associated with a lower risk of stroke and most outcomes measured, but increased incidence of major lower GI bleeding.
PMID: 26446456 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Villines TC, Schnee J, Fraeman K, Siu K, Reynolds MW, Collins J, Schwartzman E Tags: Thromb Haemost Source Type: research
More News: Atrial Fibrillation | Bleeding | Clinical Trials | Coumadin | Databases & Libraries | Gastroenterology | Heart Attack | Hematology | Hemorrhagic Stroke | Ischemic Stroke | Pradaxa | Stroke | Study | Thrombosis | Warfarin